Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2024-01-25 00:00:00 ET · period of report 2024-01-23 · accession 0001415889-24-001797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-25 | 2024-01-23 | TVTX | Heerma Peter | Chief COMMERCIAL Off | S - Sale | $9.07 | -1,559 | 78.7K | -2% | -$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-23 | S | D | 1,559 | $9.07 | 78,698 | D | — | — |